Christopher Twomey
Director/Board Member chez TANDEM DIABETES CARE, INC.
Fortune : 698 858 $ au 31/03/2024
Profil
Christopher J.
Twomey is an Independent Director at Tandem Diabetes Care, Inc. since 2013.
He is also an Independent Director at Bionano Genomics, Inc. since 2018.
Additionally, he is the Co-Manager at Twomey Family Investments LLC.
Previously, he served as an Independent Director at Mallinckrodt Hospital Products, Inc. from 2011 to 2014 and at Senomyx, Inc. from 2006 to 2018.
He was the Chief Financial Officer & Senior Vice President at Alere San Diego, Inc. from 1990 to 2007.
Prior to that, he worked as an Audit Manager at Ernst & Young LLP from 1981 to 1990.
He also held the position of Chief Financial Officer & Senior VP-Finance at Biosite, Inc. (Massachusetts) from 1990 to 2007.
Mr. Twomey completed his undergraduate degree at the University of California, Santa Barbara.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 25/05/2023 | 19 534 ( 0,03% ) | 691 699 $ | 31/03/2024 | |
BIONANO GENOMICS, INC.
0,01% | 14/06/2023 | 6 450 ( 0,01% ) | 7 160 $ | 31/03/2024 |
Postes actifs de Christopher Twomey
| Sociétés | Poste | Début |
|---|---|---|
| TANDEM DIABETES CARE, INC. | Director/Board Member | 01/07/2013 |
| BIONANO GENOMICS, INC. | Director/Board Member | 01/07/2018 |
Anciens postes connus de Christopher Twomey
| Sociétés | Poste | Fin |
|---|---|---|
| CADENCE PHARMACEUTICALS, INC. | Director/Board Member | 19/03/2014 |
| Biosite, Inc. (Massachusetts) | Director of Finance/CFO | 01/06/2007 |
Alere San Diego, Inc.
 Alere San Diego, Inc. Medical SpecialtiesHealth Technology Alere San Diego, Inc. develops, manufactures, and markets, diagnostic products. The company was founded by Kim D. Blickenstaff and Gunars E. Valkirs on June 28, 1988 and is headquartered in San Diego, CA. | Director of Finance/CFO | 01/01/2007 |
Ernst & Young LLP
 Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Comptroller/Controller/Auditor | 01/03/1990 |
| SENOMYX INC. | Director/Board Member | - |
Formation de Christopher Twomey
| University of California, Santa Barbara | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| TANDEM DIABETES CARE, INC. | Health Technology |
| BIONANO GENOMICS, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Alere San Diego, Inc.
Alere San Diego, Inc. Medical SpecialtiesHealth Technology Alere San Diego, Inc. develops, manufactures, and markets, diagnostic products. The company was founded by Kim D. Blickenstaff and Gunars E. Valkirs on June 28, 1988 and is headquartered in San Diego, CA. | Health Technology |
Ernst & Young LLP
Ernst & Young LLP Miscellaneous Commercial ServicesCommercial Services Ernst & Young LLP engages in the provision of accounting, assurance, tax, transaction, and advisory services. It specializes in the actuarial, analytics and big data, cyber security, accounting compliance and reporting, center for board matters, international financial reporting standards, country tax advisory, global trade, tax accounting, and climate change and sustainability. The company was founded in 1989 and is headquartered in New York, NY. | Commercial Services |
Senomyx, Inc.
 Senomyx, Inc. Food: Specialty/CandyConsumer Non-Durables Senomyx, Inc. engages in the development and commercialization of flavor ingredients for the packaged food, beverage, and ingredient supply industries. It develops high intensity sweeteners, savory flavors, bitter taste blockers, and cooling agents. The company was founded by Paul A. Grayson, Lubert Stryer, Yon Chien Tsien, Denis Baylor, Harold McGee, and Charles Zuker on September 16, 1998 and is headquartered in San Diego, CA. | Consumer Non-Durables |
Mallinckrodt Hospital Products, Inc.
 Mallinckrodt Hospital Products, Inc. Pharmaceuticals: MajorHealth Technology Mallinckrodt Hospital Products, Inc. operates as a biopharmaceutical company, which develops and commercializes proprietary product candidates used in the hospital setting. The firm offers OFIRMEV (acetaminophen injection), a proprietary intravenous formulation of acetaminophen for the management of mild to moderate pain, the management of moderate to severe pain with adjunctive opioid analgesics and the reduction of fever. The company was founded by Theodore R. Schroeder, David A. Socks, and Cam L. Garner on May 26, 2004 and is headquartered in Hazelwood, MO. | Health Technology |
| Biosite, Inc. (Massachusetts) |
